✦ LIBER ✦

Pathologic and biological prognostic factors of breast cancers in short- and long-term hormone replacement therapy users

✍ Scribed by Virgilio Sacchini; Stefano Zurrida; Gisella Andreoni; Alberto Luini; Viviana Galimberti; Paolo Veronesi; Mattia Intra; Giuseppe Viale; Umberto Veronesi

Book ID: 110560265
Publisher: Springer
Year: 2002
Tongue: English
Weight: 578 KB
Volume: 9
Category: Article
ISSN: 1068-9265
DOI: 10.1007/bf02573064

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hormone replacement therapy and breast c

Hormone replacement therapy and breast cancer in former users of oral contraceptives—The Norwegian Women and Cancer study

✍ Eiliv Lund; Kjersti Bakken; Vanessa Dumeaux; Vegard Andersen; Merethe Kumle 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 66 KB 👁 2 views

## Abstract Combined estrogen–progestin menopausal therapy (HRT) and combined estrogen–progestin contraceptives (OC) both increase breast cancer risk during current use and a few years after. We investigated risk of breast cancer in women who were users of HRT dependant on former history of OC use

Short-term biologic response to withdraw

Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma

✍ Ramachandran Prasad; Gary P. Boland; Angela Cramer; Elizabeth Anderson; W. Fiona 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

## Abstract ## BACKGROUND The biologic effect of continuing hormone replacement therapy (HRT) after a diagnosis of breast carcinoma is unclear. The goal of rhe current study was to determine the short‐term effect of HRT withdrawal on invasive breast carcinoma using biologic surrogate markers of tu

Correlation of high18F-FDG uptake to cli

Correlation of high18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer

✍ David Groheux; Sylvie Giacchetti; Jean-Luc Moretti; Raphael Porcher; Marc Espié; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 340 KB

Pathological prognostic factors in breas

Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up

✍ S.E. PINDER; I.O. ELLIS; M. GALEA; S. O'ROUKE; R.W. BLAMEY; C.W. ELSTON 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 609 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views